These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 29191738)

  • 1. Efficacy and safety of simultaneous vaccination with two modified live virus vaccines against porcine reproductive and respiratory syndrome virus types 1 and 2 in pigs.
    Kristensen CS; Kvisgaard LK; Pawlowski M; Holmgaard Carlsen S; Hjulsager CK; Heegaard PMH; Bøtner A; Stadejek T; Haugegaard S; Larsen LE
    Vaccine; 2018 Jan; 36(2):227-236. PubMed ID: 29191738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of a modified-live virus vaccine in pigs experimentally infected with a highly pathogenic porcine reproductive and respiratory syndrome virus type 1 (HP-PRRSV-1).
    Canelli E; Catella A; Borghetti P; Ferrari L; Ogno G; De Angelis E; Bonilauri P; Guazzetti S; Nardini R; Martelli P
    Vet Microbiol; 2018 Nov; 226():89-96. PubMed ID: 30389048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of PRRSV-2 MLV vaccines administrated via the intramuscular or intradermal route and evaluation of PRRSV transmission upon needle-free and needle delivery.
    Madapong A; Saeng-Chuto K; Tantituvanont A; Nilubol D
    Sci Rep; 2021 Nov; 11(1):23107. PubMed ID: 34845289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-mediated immune response and protective efficacy of porcine reproductive and respiratory syndrome virus modified-live vaccines against co-challenge with PRRSV-1 and PRRSV-2.
    Madapong A; Saeng-Chuto K; Boonsoongnern A; Tantituvanont A; Nilubol D
    Sci Rep; 2020 Feb; 10(1):1649. PubMed ID: 32015495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Commercial porcine reproductive and respiratory syndrome virus (PRRSV)-2 modified live virus vaccine against heterologous single and dual Korean PRRSV-1 and PRRSV-2 challenge.
    Jeong J; Kim S; Park C; Park KH; Kang I; Park SJ; Chae C
    Vet Rec; 2018 Apr; 182(17):485. PubMed ID: 29472439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune response and protective efficacy of intramuscular and intradermal vaccination with porcine reproductive and respiratory syndrome virus 1 (PRRSV-1) modified live vaccine against highly pathogenic PRRSV-2 (HP-PRRSV-2) challenge, either alone or in combination with of PRRSV-1.
    Madapong A; Saeng-Chuto K; Chaikhumwang P; Tantituvanont A; Saardrak K; Pedrazuela Sanz R; Miranda Alvarez J; Nilubol D
    Vet Microbiol; 2020 May; 244():108655. PubMed ID: 32402335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A porcine reproductive and respiratory syndrome virus candidate vaccine based on the synthetic attenuated virus engineering approach is attenuated and effective in protecting against homologous virus challenge.
    Evenson D; Gerber PF; Xiao CT; Halbur PG; Wang C; Tian D; Ni YY; Meng XJ; Opriessnig T
    Vaccine; 2016 Nov; 34(46):5546-5553. PubMed ID: 27742217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant Porcine Reproductive and Respiratory Syndrome Virus Expressing Membrane-Bound Interleukin-15 as an Immunomodulatory Adjuvant Enhances NK and γδ T Cell Responses and Confers Heterologous Protection.
    Cao QM; Ni YY; Cao D; Tian D; Yugo DM; Heffron CL; Overend C; Subramaniam S; Rogers AJ; Catanzaro N; LeRoith T; Roberts PC; Meng XJ
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29643245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of four commercial PRRSV MLV vaccines in herds with co-circulation of PRRSV-1 and PRRSV-2.
    Oh T; Kim H; Park KH; Jeong J; Yang S; Kang I; Chae C
    Comp Immunol Microbiol Infect Dis; 2019 Apr; 63():66-73. PubMed ID: 30961820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination against porcine reproductive and respiratory syndrome virus (PRRSV) reduces the magnitude and duration of viremia following challenge with a virulent heterologous field strain.
    Calvert JG; Keith ML; Pearce DS; Lenz MC; King VL; Diamondidis YA; Ankenbauer RG; Martinon NC
    Vet Microbiol; 2017 Jun; 205():80-83. PubMed ID: 28622868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pigs immunized with Chinese highly pathogenic PRRS virus modified live vaccine are protected from challenge with North American PRRSV strain NADC-20.
    Galliher-Beckley A; Li X; Bates JT; Madera R; Waters A; Nietfeld J; Henningson J; He D; Feng W; Chen R; Shi J
    Vaccine; 2015 Jul; 33(30):3518-25. PubMed ID: 26049004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-administration of saponin quil A and PRRSV-1 modified-live virus vaccine up-regulates gene expression of type I interferon-regulated gene, type I and II interferon, and inflammatory cytokines and reduces viremia in response to PRRSV-2 challenge.
    Charerntantanakul W; Pongjaroenkit S
    Vet Immunol Immunopathol; 2018 Nov; 205():24-34. PubMed ID: 30458999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of two genetically distant type 2 porcine reproductive and respiratory syndrome virus (PRRSV) modified live vaccines against Vietnamese highly pathogenic PRRSV.
    Do DT; Park C; Choi K; Jeong J; Nguyen TT; Nguyen KD; Vo DT; Chae C
    Vet Microbiol; 2015 Sep; 179(3-4):233-41. PubMed ID: 26149103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An interferon inducing porcine reproductive and respiratory syndrome virus vaccine candidate elicits protection against challenge with the heterologous virulent type 2 strain VR-2385 in pigs.
    Fontanella E; Ma Z; Zhang Y; de Castro AM; Shen H; Halbur PG; Opriessnig T
    Vaccine; 2017 Jan; 35(1):125-131. PubMed ID: 27876202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral immune responses and viral shedding following vaccination with modified live porcine reproductive and respiratory syndrome virus vaccines.
    Madapong A; Temeeyasen G; Saeng-Chuto K; Tripipat T; Navasakuljinda W; Boonsoongnern A; Tantituvanont A; Nilubol D
    Arch Virol; 2017 Jan; 162(1):139-146. PubMed ID: 27695957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-protective immunity to porcine reproductive and respiratory syndrome virus by intranasal delivery of a live virus vaccine with a potent adjuvant.
    Dwivedi V; Manickam C; Patterson R; Dodson K; Murtaugh M; Torrelles JB; Schlesinger LS; Renukaradhya GJ
    Vaccine; 2011 May; 29(23):4058-66. PubMed ID: 21419162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Two Commercial Type 1 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Modified Live Vaccines against Heterologous Type 1 and Type 2 PRRSV Challenge in Growing Pigs.
    Kim T; Park C; Choi K; Jeong J; Kang I; Park SJ; Chae C
    Clin Vaccine Immunol; 2015 Jun; 22(6):631-40. PubMed ID: 25855554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of routes of immunization of a live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in a heterologous virus challenge study.
    Ouyang K; Hiremath J; Binjawadagi B; Shyu DL; Dhakal S; Arcos J; Schleappi R; Holman L; Roof M; Torrelles JB; Renukaradhya GJ
    Vet Res; 2016 Mar; 47():45. PubMed ID: 26988085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: Clinical protection and cell-mediated immunity.
    Martelli P; Gozio S; Ferrari L; Rosina S; De Angelis E; Quintavalla C; Bottarelli E; Borghetti P
    Vaccine; 2009 Jun; 27(28):3788-99. PubMed ID: 19442420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the intranasal route for porcine reproductive and respiratory disease modified-live virus vaccination.
    Opriessnig T; Rawal G; McKeen L; Filippsen Favaro P; Halbur PG; Gauger PC
    Vaccine; 2021 Nov; 39(47):6852-6859. PubMed ID: 34706840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.